BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Sina Fuchs, Monika Bayer, Richard Taubert, Michael P. Manns, Josef M. Pfeilschifter, Urs Christen, Edith Hintermann. Effects of adenovirus‐induced hepatocyte damage on chronic bile duct inflammation in a sclerosing cholangitis mouse modelLiver International 2019; 39(12): 2330 doi: 10.1111/liv.14183
2
D. Robert Dufour. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics2012; : 1637 doi: 10.1016/B978-1-4160-6164-9.00050-0
3
Kazuhito Kawata, Yoshimasa Kobayashi, M. Eric Gershwin, Christopher L. Bowlus. The Immunophysiology and Apoptosis of Biliary Epithelial Cells: Primary Biliary Cirrhosis and Primary Sclerosing CholangitisClinical Reviews in Allergy & Immunology 2012; 43(3): 230 doi: 10.1007/s12016-012-8324-0
4
John E. Eaton, Jayant A. Talwalkar, Keith D. Lindor. The Autoimmune Diseases2014; : 925 doi: 10.1016/B978-0-12-384929-8.00063-0
5
Evaggelia Liaskou, Gideon M. Hirschfield, M. Eric Gershwin. Mechanisms of tissue injury in autoimmune liver diseasesSeminars in Immunopathology 2014; 36(5): 553 doi: 10.1007/s00281-014-0439-3
6
Sebastian Torben Jendrek, Daniel Gotthardt, Thomas Nitzsche, Laila Widmann, Tobias Korf, Maike Anna Michaels, Karl-Heinz Weiss, Evaggelia Liaskou, Mette Vesterhus, Tom Hemming Karlsen, Swantje Mindorf, Peter Schemmer, Florian Bär, Bianca Teegen, Torsten Schröder, Marc Ehlers, Christoph Matthias Hammers, Lars Komorowski, Hendrik Lehnert, Klaus Fellermann, Stefanie Derer, Johannes Roksund Hov, Christian Sina. Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitisGut 2017; 66(1): 137 doi: 10.1136/gutjnl-2016-311739
7
José Franco. Liver Disorders2017; : 289 doi: 10.1007/978-3-319-30103-7_17
8
Claudia O. Zein, Keith D. Lindor. Latest and Emerging Therapies for Primary Biliary Cirrhosis and Primary Sclerosing CholangitisCurrent Gastroenterology Reports 2010; 12(1): 13 doi: 10.1007/s11894-009-0079-2
9
Matteo Bramuzzo, Stefano Martelossi, Giuliano Torre, Sabrina Cardile, Serena Arrigo, Silvia Vignola, Federica Ferrari, Giovanna Zuin, Maria Teresa Illiceto, Marco Gasparetto, Salvatore Pellegrino, Claudio Romano, Giuseppe Maggiore, Marcella Montico, Marina Aloi. Clinical Features and Risk Factors of Autoimmune Liver Involvement in Pediatric Inflammatory Bowel DiseaseJournal of Pediatric Gastroenterology and Nutrition 2016; 63(2): 259 doi: 10.1097/MPG.0000000000001078
10
José Franco. Pancreas and Biliary Disease2016; : 321 doi: 10.1007/978-3-319-28089-9_14
11
Marcial Sebode, Christina Weiler-Normann, Timur Liwinski, Christoph Schramm. Autoantibodies in Autoimmune Liver Disease—Clinical and Diagnostic RelevanceFrontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00609
12
Kirsten Muri Boberg, Roger W. Chapman, Gideon M. Hirschfield, Ansgar W. Lohse, Michael P. Manns, Erik Schrumpf. Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issueJournal of Hepatology 2011; 54(2): 374 doi: 10.1016/j.jhep.2010.09.002
13
“Autoimmune(-Like)” Drug and Herb Induced Liver Injury: New Insights into Molecular PathogenesisInternational Journal of Molecular Sciences 2017; 18(9): 1954 doi: 10.3390/ijms18091954
14
A. Schreiber, B. Rudolph, A. Kahl, R. Kettritz. Akutes Nierenversagen bei einem lebertransplantierten PatientenDer Nephrologe 2015; 10(5): 416 doi: 10.1007/s11560-014-0932-7
15
Tom H. Karlsen, Trine Folseraas, Douglas Thorburn, Mette Vesterhus. Primary sclerosing cholangitis – a comprehensive reviewJournal of Hepatology 2017; 67(6): 1298 doi: 10.1016/j.jhep.2017.07.022
16
Elisabeth M.G. de Vries, Ulrich Beuers, Cyriel Y. Ponsioen. Biomarkers for disease progression of primary sclerosing cholangitisCurrent Opinion in Gastroenterology 2015; 31(3): 239 doi: 10.1097/MOG.0000000000000163
17
Hiroyuki Isayama, Susumu Tazuma, Norihiro Kokudo, Atsushi Tanaka, Toshio Tsuyuguchi, Takahiro Nakazawa, Kenji Notohara, Suguru Mizuno, Nobuhisa Akamatsu, Masahiro Serikawa, Itaru Naitoh, Yoshiki Hirooka, Toshifumi Wakai, Takao Itoi, Tomoki Ebata, Shinji Okaniwa, Terumi Kamisawa, Hiroki Kawashima, Atsushi Kanno, Keiichi Kubota, Masami Tabata, Michiaki Unno, Hajime Takikawa. Clinical guidelines for primary sclerosing cholangitis 2017Journal of Gastroenterology 2018; 53(9): 1006 doi: 10.1007/s00535-018-1484-9
18
Xiaojun Jiang, Tom H. Karlsen. Genetics of primary sclerosing cholangitis and pathophysiological implicationsNature Reviews Gastroenterology & Hepatology 2017; 14(5): 279 doi: 10.1038/nrgastro.2016.154
19
Kelly Hudspeth, Elena Pontarini, Paolo Tentorio, Matteo Cimino, Matteo Donadon, Guido Torzilli, Enrico Lugli, Silvia Della Bella, M. Eric Gershwin, Domenico Mavilio. The role of natural killer cells in autoimmune liver disease: A comprehensive reviewJournal of Autoimmunity 2013; 46: 55 doi: 10.1016/j.jaut.2013.07.003
20
Priscila Menezes Ferri, Ana Cristina Simões e Silva, Soraya Luiza Campos Silva, Diego Junior Queiroga de Aquino, Eleonora Druve Tavares Fagundes, Débora Marques de Miranda, Alexandre Rodrigues Ferreira. The Role of Genetic and Immune Factors for the Pathogenesis of Primary Sclerosing Cholangitis in ChildhoodGastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/3905240
21
U. Spengler. Differenzialdiagnose IkterusDer Gastroenterologe 2010; 5(4): 363 doi: 10.1007/s11377-009-0390-3
22
Paola De Angelis, Renato Tambucci, Erminia Romeo, Francesca Rea, Claudia Caloisi, Tamara Caldaro, Giovanni Federici di Abriola, Francesca Foschia, Filippo Torroni, L. Monti, Luigi Dall'Oglio. Does an isolated benign choledochal stricture hide a PSC?Journal of Pediatric Surgery 2013; 48(5): 1006 doi: 10.1016/j.jpedsurg.2013.02.020
23
Christopher L. Bowlus. Liver Immunology2014; : 45 doi: 10.1007/978-3-319-02096-9_4
24
Shikib Mostamand, Shauna Schroeder, Jacqueline Schenkein, Tamir Miloh. Infliximab-Associated Immunomediated Hepatitis in Children With Inflammatory Bowel DiseaseJournal of Pediatric Gastroenterology and Nutrition 2016; 63(1): 94 doi: 10.1097/MPG.0000000000001137
25
Lena Berglin, Niklas K. Björkström, Annika Bergquist. Primary sclerosing cholangitis is associated with autoreactive IgA antibodies against biliary epithelial cellsScandinavian Journal of Gastroenterology 2013; 48(6): 719 doi: 10.3109/00365521.2013.786131
26
T. Liwinski, C. Schramm. Primär sklerosierende CholangitisDer Internist 2018; 59(6): 551 doi: 10.1007/s00108-018-0428-z
27
Johannes R. Hov, Kirsten M. Boberg, Eli Taraldsrud, Mette Vesterhus, Maria Boyadzhieva, Inger Camilla Solberg, Erik Schrumpf, Morten H. Vatn, Benedicte A. Lie, Øyvind Molberg, Tom H. Karlsen. Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitisLiver International 2017; 37(3): 458 doi: 10.1111/liv.13238
28
Abin Chandrakumar, Rachael Loeppky, Mark Deneau, Wael El-Matary. Inflammatory Bowel Disease in Children with Elevated Serum Gamma Glutamyltransferase LevelsThe Journal of Pediatrics 2019; 215: 144 doi: 10.1016/j.jpeds.2019.07.065
29
Rodrigo Liberal, Giorgina Mieli-Vergani, Diego Vergani. Clinical significance of autoantibodies in autoimmune hepatitisJournal of Autoimmunity 2013; 46: 17 doi: 10.1016/j.jaut.2013.08.001
30
Erik Schrumpf, Kirsten Muri Boberg, Tom H. Karlsen. Primary sclerosing cholangitis – the Norwegian experienceScandinavian Journal of Gastroenterology 2015; 50(6): 781 doi: 10.3109/00365521.2015.1028996
31
Channakeshava Sokke Umeshappa, Santiswarup Singha, Jesus Blanco, Kun Shao, Roopa Hebbandi Nanjundappa, Jun Yamanouchi, Albert Parés, Pau Serra, Yang Yang, Pere Santamaria. Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicinesNature Communications 2019; 10(1) doi: 10.1038/s41467-019-09893-5
32
John M. Vierling. Primary Sclerosing Cholangitis2017; : 111 doi: 10.1007/978-3-319-40908-5_9
33
Rosebella A. Iseme, Mark McEvoy, Brian Kelly, Linda Agnew, Frederick R. Walker, Michael Boyle, John Attia. A Cross-Sectional Study of the Association between Autoantibodies and Qualitative Ultrasound Index of Bone in an Elderly Sample without Clinical Autoimmune DiseaseJournal of Immunology Research 2018; 2018: 1 doi: 10.1155/2018/9407971
34
Claudia O. Zein. Primary Sclerosing CholangitisClinics in Liver Disease 2013; 17(2): 211 doi: 10.1016/j.cld.2012.11.003
35
C. Buffet. Cholangites sclérosantesEMC - Hépatologie 2011; 6(1): 1 doi: 10.1016/S1155-1976(11)50375-4
36
Kirsten Muri Boberg. Autoimmune Hepatitis2012; : 217 doi: 10.1007/978-1-60761-569-9_12
37
Pietro Invernizzi. Geoepidemiology of autoimmune liver diseasesJournal of Autoimmunity 2010; 34(3): J300 doi: 10.1016/j.jaut.2009.12.002
38
EASL Clinical Practice Guidelines: Management of cholestatic liver diseasesJournal of Hepatology 2009; 51(2): 237 doi: 10.1016/j.jhep.2009.04.009
39
Sarajo Kumar Mohanta, Changjun Yin, Li Peng, Prasad Srikakulapu, Vineela Bontha, Desheng Hu, Falk Weih, Christian Weber, Norbert Gerdes, Andreas J.R. Habenicht. Artery Tertiary Lymphoid Organs Contribute to Innate and Adaptive Immune Responses in Advanced Mouse AtherosclerosisCirculation Research 2014; 114(11): 1772 doi: 10.1161/CIRCRESAHA.114.301137
40
Keisuke Kakisaka, Kazuyuki Ishida, Kojiro Kataoka, Yuji Suzuki, Shunichi Yanai, Hidekatsu Kuroda, Tamotsu Sugai, Takayuki Matsumoto, Yasuhiro Takikawa. Reversible sclerosing cholangitis with ulcerative colitisPathology International 2016; 66(7): 404 doi: 10.1111/pin.12427
41
Haiyan Zhang, Patrick S.C. Leung, M. Eric Gershwin, Xiong Ma. How the biliary tree maintains immune tolerance?Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1367 doi: 10.1016/j.bbadis.2017.08.019
42
Brian K. Chung, Bardia T. Guevel, Gary M. Reynolds, D.B.R.K. Gupta Udatha, Eva Kristine Klemsdal Henriksen, Zania Stamataki, Gideon M. Hirschfield, Tom Hemming Karlsen, Evaggelia Liaskou. Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitisJournal of Autoimmunity 2017; 77: 45 doi: 10.1016/j.jaut.2016.10.003
43
K. Wiencke, K.M. Boberg. Current consensus on the management of primary sclerosing cholangitisClinics and Research in Hepatology and Gastroenterology 2011; 35(12): 786 doi: 10.1016/j.clinre.2011.04.007
44
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. Serology in autoimmune hepatitis: A clinical-practice approachEuropean Journal of Internal Medicine 2018; 48: 35 doi: 10.1016/j.ejim.2017.10.006
45
Piotr Milkiewicz, Marcin Krawczyk, Ewa Wunsch, Cyriel Ponsioen, Gideon M. Hirschfield, Stefan G. Hubscher. Primary Sclerosing Cholangitis With Features of Autoimmune Hepatitis: Exploring the Global Variation in ManagementHepatology Communications 2020;  doi: 10.1002/hep4.1467
46
Sang-Heum Park, Hoo Rim Song, Sung Won Lee, Tae Hoon Lee. Wouldn't Human Understanding be Necessary to Treat Patients with Pancreaticobiliary Disease More Effectively?The Korean Journal of Pancreas and Biliary Tract 2018; 23(3): 89 doi: 10.15279/kpba.2018.23.3.89
47
Jason B. Samarasena, Ke-Qin Hu. Hepatobiliary Manifestations of Gastrointestinal and Nutritional DisordersClinics in Liver Disease 2011; 15(1): 89 doi: 10.1016/j.cld.2010.09.003
48
P. J. Trivedi, G. M. Hirschfield. Review article: overlap syndromes and autoimmune liver diseaseAlimentary Pharmacology & Therapeutics 2012; 36(6): 517 doi: 10.1111/j.1365-2036.2012.05223.x
49
Roger Chapman, Johan Fevery, Anthony Kalloo, David M. Nagorney, Kirsten Muri Boberg, Benjamin Shneider, Gregory J. Gores. Diagnosis and management of primary sclerosing cholangitisHepatology 2010; 51(2): 660 doi: 10.1002/hep.23294
50
Samar H. Ibrahim, Keith D. Lindor. Current Management of Primary Sclerosing Cholangitis in Pediatric PatientsPediatric Drugs 2011; 13(2): 87 doi: 10.2165/11586500-000000000-00000
51
Elisabeth Krones, Ivo Graziadei, Michael Trauner, Peter Fickert. Evolving concepts in primary sclerosing cholangitisLiver International 2011; : n/a doi: 10.1111/j.1478-3231.2011.02607.x
52
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overviewJournal of Autoimmunity 2018; 95: 144 doi: 10.1016/j.jaut.2018.10.004
53
Tom H. Karlsen, Erik Schrumpf, Kirsten M. Boberg. Update on primary sclerosing cholangitisDigestive and Liver Disease 2010; 42(6): 390 doi: 10.1016/j.dld.2010.01.011
54
Sigrid Næss, Alexey Shiryaev, Johannes R. Hov, Andre Franke, Tom H. Karlsen. Genetics in primary sclerosing cholangitisClinics and Research in Hepatology and Gastroenterology 2012; 36(4): 325 doi: 10.1016/j.clinre.2012.02.003
55
Krisztina Hagymási, Zsolt Tulassay. Review of overlap syndromes of autoimmune liver diseases. Difficulties in the diagnosis and treatmentOrvosi Hetilap 2013; 154(24): 923 doi: 10.1556/OH.2013.29640
56
Klaus Felix, Oliver Hauck, Martina Schnölzer, Tore Kempf, Uwe Warnken, Kathrin Schneider, Frank Bergmann, Stefan Fritz, Jens Werner. Identification of Novel Serum Autoantibodies for Differential Diagnosis of Autoimmune Pancreatitis and Pancreatic Ductal AdenocarcinomaPancreas 2016; 45(9): 1309 doi: 10.1097/MPA.0000000000000647
57
Tom Hemming Karlsen, Kirsten Muri Boberg. Sherlock's Diseases of the Liver and Biliary System2018; : 341 doi: 10.1002/9781119237662.ch18
58
Brian K. Chung, Eva Kristine Klemsdal Henriksen, Kristin Kaasen Jørgensen, Tom H. Karlsen, Gideon M. Hirschfield, Evaggelia Liaskou. Gut and Liver B Cells of Common Clonal Origin in Primary Sclerosing Cholangitis–Inflammatory Bowel DiseaseHepatology Communications 2018; 2(8): 960 doi: 10.1002/hep4.1200
59
Senka Dobric, Dragan Popovic, Milos Nikolic, Sladjana Andrejevic, Milan Spuran, Branka Bonaci-Nikolic. Anti-neutrophil cytoplasmic antibodies (ANCA) specific for one or several antigens: useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitisClinical Chemistry and Laboratory Medicine 2012; 50(3) doi: 10.1515/cclm.2011.797
60
Simona Marzorati, Pietro Invernizzi, Ana Lleo. Making Sense of Autoantibodies in Cholestatic Liver DiseasesClinics in Liver Disease 2016; 20(1): 33 doi: 10.1016/j.cld.2015.08.003
61
Albert Parés. Colangitis esclerosante primaria: diagnóstico, pronóstico y tratamientoGastroenterología y Hepatología 2011; 34(1): 41 doi: 10.1016/j.gastrohep.2010.02.006
62
Biljana Radovanović-Dinić, Snežana Tešić-Rajković, Valentina Zivkovic, Saša Grgov. Clinical connection between rheumatoid arthritis and liver damageRheumatology International 2018; 38(5): 715 doi: 10.1007/s00296-018-4021-5
63
Tom Hemming Karlsen, Gideon M. Hirschfield. Primary Sclerosing Cholangitis2017; : 99 doi: 10.1007/978-3-319-40908-5_8
64
Hanh D. Vo, Jiliu Xu, Simon S. Rabinowitz, Stanley E. Fisher, Steven M. Schwarz. The Liver in Pediatric Gastrointestinal DiseaseJournal of Pediatric Gastroenterology and Nutrition 2014; 59(3): 288 doi: 10.1097/MPG.0000000000000444
65
Ban-Hock Toh. Diagnostic autoantibodies for autoimmune liver diseasesClinical & Translational Immunology 2017; 6(5): e139 doi: 10.1038/cti.2017.14
66
Antonio Di Sabatino, Federico Biagi, Marco Lenzi, Luca Frulloni, Marco Vincenzo Lenti, Paolo Giuffrida, Gino Roberto Corazza. Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseasesDigestive and Liver Disease 2017; 49(9): 947 doi: 10.1016/j.dld.2017.06.010
67
Verghese George, Varaha Sairam Tammisetti, Venkateswar Rao Surabhi, Alampady K. Shanbhogue. Chronic Fibrosing Conditions in Abdominal ImagingRadioGraphics 2013; 33(4): 1053 doi: 10.1148/rg.334125081
68
Henrike Lenzen, Tobias J. Weismüller, Ahmed A. Negm, Jenny Wlecke, Stephanie Loges, Christian P. Strassburg, Michael P. Manns, Tim O. Lankisch. Antineutrophil cytoplasmic antibodies in bile are associated with disease activity in primary sclerosing cholangitisScandinavian Journal of Gastroenterology 2013; 48(10): 1205 doi: 10.3109/00365521.2013.825313